Cohort study compares pathogenic variant prevalence in postmenopausal women with breast cancer, informing guidelines for genetic testing.
This study uses Women’s Health Initiative data to compare the prevalence of pathogenic variants (PVs) in breast cancer susceptibility genes in postmenopausal women with vs without breast cancer to guide decisions about who should undergo PV testing.
No takes yet. Share an insight, caveat, or question.
Kurian et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: